{"id":"W4282978920","doi":"10.1158/1538-7445.am2022-ct521","title":"Abstract CT521: Phase 1b trial of the MNK1/2 inhibitor tomivosertib combined with paclitaxel in patients with metastatic breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Concordia University; McGill University; University of British Columbia; University of Alberta; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Tolerability; Pharmacokinetics; Metastatic breast cancer; Pharmacology; Internal medicine; Pharmacodynamics; Breast cancer; Cmax; Cancer; Oncology; Gastroenterology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008294884,0.001847023,0.001693054,0.0004499333,0.0004180328,0.001201204,0.000858584,0.001089098,0.006757255],"category_scores_gemma":[0.0006726916,0.0004953364,0.0007790453,0.0005720519,0.0006000972,0.0008034731,0.0002955102,0.0028348,0.001557149],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001544054,"about_ca_system_score_gemma":0.001497651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002657282,"about_ca_topic_score_gemma":0.009385494,"domain_scores_codex":[0.9997701,0.00009410124,0.00001181466,0.00004146269,0.00002613479,0.00005639329],"domain_scores_gemma":[0.9996895,0.00003948758,0.00006504742,0.00001730293,0.00002139163,0.0001672956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6502177,0.03775524,0.01030431,0.002215478,0.002039109,0.0007115162,0.0003256282,0.00643156,0.09249447,0.0007844067,0.02880644,0.1679143],"study_design_scores_gemma":[0.6437302,0.3085302,0.02759997,0.0001780891,0.0006197228,0.0008916701,0.0001019607,0.003184798,0.006922384,0.0003345381,0.007836313,0.00007017863],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9768153,0.005447432,0.0005164896,0.001393151,0.0001895497,0.002410562,0.004808793,0.0003146439,0.008104027],"genre_scores_gemma":[0.9744239,0.003623892,0.001367095,0.00179801,0.0002423337,0.002035627,0.009432432,0.00006793912,0.007008743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006757255,"threshold_uncertainty_score":0.0226053,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03467389512554236,"score_gpt":0.3656664726997678,"score_spread":0.3309925775742254,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}